|
|
|
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced new pre-clinical data from its ALN-VSP program presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International...
CARLSBAD, Calif., Nov. 19 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. announces the following webcast: What: Isis Pharmaceuticals' R&D Webcast Presentation When: Thursday, December 3, 2009, at 8:30 a.m. PT / 11:30 a.m....
FREMONT, Calif., Nov. 19 /PRNewswire/ -- Quark Pharmaceuticals, Inc., the leader in siRNA therapeutics in clinicals, announced today that four of its siRNA R&D platform based programs have met clinical development milestones;...
CAMBRIDGE, Mass. & CARLSBAD, Calif.----Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with homozygous familial hypercholesterolemia were presented today at the...
Vancouver, BC, November 13, 2009--(T-Net)--Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today its operating results...
Several of New England’s life sciences firms had good news to report this week. —Ryan gave a run-down of the key insights to emerge from our Xconomy Forum on pharma innovation. Sirtris CEO Christoph Westphal, for example,...
Update on Pipeline Includes New Pre-clinical In Vivo Data Demonstrating that ALN-TTR Blocks Pathogenic Tissue Deposition of Mutant TTR Protein by Greater than 95% - - Update on Technology Efforts Includes New Data on...
Alnylam Pharmaceuticals Inc. (NasdaqGM: ALNY - News) reported a third-quarter loss of 22 cents per share, below the Zacks Consensus Estimate of 24 cents but wider than the year-ago loss of 7 cents. The higher loss in the...
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 12, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today its...
NYSE Amex Equities Exchange Symbol - UEC AUSTIN, TX, Nov. 12 - Uranium Energy Corp (NYSE-AMEX: UEC, "the Company") announces that the Company has entered into an option agreement (the "Option Agreement"...
